Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for PASG.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 3.218M
March 31, 2026 3.208M
December 31, 2025 3.183M
September 30, 2025 3.179M
June 30, 2025 3.179M
March 31, 2025 62.15M
December 31, 2024 62.06M
September 30, 2024 61.77M
June 30, 2024 61.75M
March 31, 2024 61.61M
December 31, 2023 54.94M
September 30, 2023 54.81M
June 30, 2023 54.75M
March 31, 2023 54.63M
December 31, 2022 54.61M
September 30, 2022 54.55M
Date Value
June 30, 2022 54.46M
March 31, 2022 54.31M
December 31, 2021 54.24M
September 30, 2021 54.02M
June 30, 2021 53.96M
March 31, 2021 53.85M
December 31, 2020 45.61M
September 30, 2020 45.53M
June 30, 2020 45.44M
March 31, 2020 45.35M
December 31, 2019 45.80M
September 30, 2019 2.290M
June 30, 2019 45.80M
March 31, 2019 2.268M
December 31, 2018 45.80M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
ARS Pharmaceuticals, Inc. 99.44M
ACADIA Pharmaceuticals, Inc. 172.13M
Alnylam Pharmaceuticals, Inc. 133.73M
Anika Therapeutics, Inc. 13.38M
Savara, Inc. 205.40M